Dynamic T‐Cell Reprogramming Modulates the Treatment Outcome of Neoadjuvant Immunochemotherapy in Non‐Small‐Cell Lung Cancer

ABSTRACT Although immunochemotherapy sheds light on neoadjuvant strategies, about two‐thirds of patients still respond poorly to perioperative chemoimmunotherapy. Hence, it is crucial to investigate the underlying response mechanism to improve the prognosis of these patients. In this study, we utili...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rui Jin, Anhao Tian, Weina Lu, Qiyuan Wang, Xiuzhen Li, Sai Zhang, Guanxin Xu, Kai Zhu, Peng Li, Jianan Li, Wei Chen, Weiwei Yin, Wen Li, Yang Xia
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-04-01
coleção:	MedComm
Assuntos:	immunochemotherapy neoadjuvant non‐small‐cell lung cancer (NSCLC) T cell
Acesso em linha:	https://doi.org/10.1002/mco2.70690
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!